| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.8705 | 
      | Human Intestinal Absorption | HIA+ | 0.9313 | 
      | Caco-2 Permeability | Caco2- | 0.6958 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8147 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9876 | 
                                                     | Non-inhibitor | 0.9911 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9524 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7888 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8130 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9003 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.8052 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9256 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9084 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9547 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9406 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9544 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9873 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9803 | 
                                                                    | Non-inhibitor | 0.9844 | 
      | AMES Toxicity | Non AMES toxic | 0.9146 | 
      | Carcinogens | Non-carcinogens | 0.6069 | 
      | Fish Toxicity | High FHMT | 0.7981 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.9255 | 
      | Honey Bee Toxicity | High HBT | 0.7643 | 
      | Biodegradation | Ready biodegradable | 0.8393 | 
      | Acute Oral Toxicity | III | 0.4559 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7340 |